Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Familial Cancer
Published in: Familial Cancer 2/2001

01-04-2001

Mutations of the 'minor' mismatch repair gene MSH6 in typical and atypical hereditary nonpolyposis colorectal cancer

Authors: Emanuela Lucci-Cordisco, Valentina Rovella, Stefania Carrara, Antonio Percesepe, Monica Pedroni, Alfonso Bellacosa, Oana Caluseriu, Mara Forasarig, Marcello Anti, Giovanni Neri, Maurizio Ponz de Leon, Alessandra Viel, Maurizio Genuardi

Published in: Familial Cancer | Issue 2/2001

Login to get access
Metadata
Title
Mutations of the 'minor' mismatch repair gene MSH6 in typical and atypical hereditary nonpolyposis colorectal cancer
Authors
Emanuela Lucci-Cordisco
Valentina Rovella
Stefania Carrara
Antonio Percesepe
Monica Pedroni
Alfonso Bellacosa
Oana Caluseriu
Mara Forasarig
Marcello Anti
Giovanni Neri
Maurizio Ponz de Leon
Alessandra Viel
Maurizio Genuardi
Publication date
01-04-2001
Publisher
Kluwer Academic Publishers
Published in
Familial Cancer / Issue 2/2001
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1023/A:1013872914474

Other articles of this Issue 2/2001

Familial Cancer 2/2001 Go to the issue

Commentary

Commentary on Eccles et al.: Familial breast cancer: an investigation into the outcome of treatment for early stage disease

OriginalPaper

FAP associated thyroid carcinoma in mother and her daughter

OriginalPaper

The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) – Results of an international collaborative study

OriginalPaper

Café-au-lait spots and early onset colorectal neoplasia: a variant of HNPCC?

OriginalPaper

Preventive measures in Peutz-Jeghers syndrome

OriginalPaper

Familial adenomatous polyposis at the Tel Aviv Medical Center: demographic and clinical features
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits